98%
921
2 minutes
20
Appendiceal neuroendocrine tumors are a rare subset of well-differentiated neuroendocrine tumors, comprising <1% of all malignancies. Appendiceal cancer is particularly rare, affecting approximately one to two individuals per one million annually in the United States. Appendiceal neuroendocrine tumors have an estimated incidence of 7/100,000 person-years in the United States. In this report, we present the case of a 19-year-old female who arrived to the emergency department with recurrent right lower quadrant pain, unresponsive to initial management for suspected acute appendicitis, and urinary tract infection. Advanced imaging revealed an appendiceal mucocele. The patient underwent appendectomy, and histopathology confirmed a well-differentiated appendiceal neuroendocrine tumor (grade 2) with lymphovascular invasion. A subsequent right hemicolectomy identified metastatic disease in 6 out of 27 lymph nodes. Unfortunately, the patient was lost to follow-up shortly after surgery. This case underscores the diagnostic complexities of appendiceal neuroendocrine tumors, which are often incidental findings during appendectomy and may present with nonspecific or atypical symptoms. It highlights the critical role of tumor size, grade, and histopathological evaluation in guiding management decisions, as well as the importance of a multidisciplinary approach to treatment. Moreover, it emphasizes the necessity of vigilant follow-up, particularly in young patients, to address the long-term implications of this rare malignancy and improve outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12381439 | PMC |
http://dx.doi.org/10.1177/2050313X251369764 | DOI Listing |
SAGE Open Med Case Rep
August 2025
Department of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.
Appendiceal neuroendocrine tumors are a rare subset of well-differentiated neuroendocrine tumors, comprising <1% of all malignancies. Appendiceal cancer is particularly rare, affecting approximately one to two individuals per one million annually in the United States. Appendiceal neuroendocrine tumors have an estimated incidence of 7/100,000 person-years in the United States.
View Article and Find Full Text PDFRom J Morphol Embryol
August 2025
Department of Surgery, University of Medicine and Pharmacy of Craiova, Romania;
Background∕Objectives: Appendiceal neuroendocrine tumors (aNETs), though rare and often incidentally discovered, have shown a rising incidence, particularly among younger individuals, due to improved diagnostic practices, and are generally associated with favorable prognosis, with current evidence supporting conservative, individualized management and tailored surveillance strategies based on tumor size, grade, histopathological features, and imaging findings. Study selection for review: A PubMed search was performed to explore the current understanding of aNETs, with emphasis on their etiopathogenesis, diagnostic criteria, and therapeutic strategies. Case presentation: A 42-year-old man underwent an uneventful laparoscopic appendectomy for acute appendicitis, during which a 5 cm appendix with a pale, nodular tip suggestive of a lesion was resected, leading to the incidental discovery of an aNET.
View Article and Find Full Text PDFInflamm Bowel Dis
August 2025
Pediatric Gastroenterology Unit, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Background: Data on upadacitinib therapy for pediatric acute severe ulcerative colitis (ASC) are scarce. We aimed to evaluate the effectiveness and safety of upadacitinib as a salvage therapy in pediatric ASC.
Methods: Children and adolescents with ASC who were treated with upadacitinib for the induction of remission were enrolled in this retrospective multicenter study.
Ann Surg Oncol
August 2025
Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Endocr Oncol
January 2025
Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Objective: Patients with appendiceal neuroendocrine tumours (aNETs) have an excellent prognosis. Appendiceal goblet cell adenocarcinomas (aGCAs), formerly called goblet carcinoid, show overlapping features with aNETs. Many discrepancies exist between studies regarding prognostication of patients with aNETs.
View Article and Find Full Text PDF